Fogarty International Center; Notice of Meeting, 54340-54341 [2023-17141]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
54340
Federal Register / Vol. 88, No. 153 / Thursday, August 10, 2023 / Notices
one or more of the following
procedures: (i) use non-flying, flightimpaired, or sterile arthropods; (ii) use
non-motile or sterile strains of small
animals; (iii) conduct experiments at a
time of year that precludes the survival
of escaping organisms; (iv) use animals
that have an obligate association with a
plant that is not present within the
dispersal range of the organism; or (v)
prevent the escape of organisms present
in run-off water by chemical treatment
or evaporation of run-off water.
Containment for arthropods is described
in the Arthropod Containment
Guidelines and Addendum 1
Containment Practices for Arthropods
Modified with Engineered Transgenes
Capable of Gene Drive (see Appendix
G–III–B).
Appendix M–III–D currently states:
Appendix M–III–D. Other research
with non-laboratory animals, which
may not appropriately be conducted
under conditions described in
Appendix M, may be conducted safely
by applying practices routinely used for
controlled culture of these biota. In
aquatic systems, for example, BL1
equivalent conditions could be met by
utilizing growth tanks that provide
adequate physical means to avoid the
escape of the aquatic species, its
gametes, and introduced exogenous
genetic material. A mechanism shall be
provided to ensure that neither the
organisms nor their gametes can escape
into the supply or discharge system of
the rearing container (e.g., tank,
aquarium, etc.) Acceptable barriers
include appropriate filtration,
irradiation, heat treatment, chemical
treatment, etc. Moreover, the top of the
rearing container shall be covered to
avoid escape of the organism and its
gametes. In the event of tank rupture,
leakage, or overflow, the construction of
the room containing these tanks should
prevent the organisms and gametes from
entering the building’s drains before the
organism and its gametes have been
inactivated.
Other types of non-laboratory animals
(e.g., nematodes, arthropods, and certain
forms of smaller animals) may be
accommodated by using the appropriate
BL1 through BL4 or BL1–P through
BL4–P containment practices and
procedures as specified in Appendices
G and L.
Appendix M–III–D is proposed to be
amended to:
Appendix M–III–D. Research with
animals, which may not appropriately
be conducted under conditions
described in Appendix M, may be
conducted safely by applying practices
routinely used for controlled culture of
these biota. In aquatic systems, for
VerDate Sep<11>2014
17:28 Aug 09, 2023
Jkt 259001
example, BL1 equivalent conditions
could be met by utilizing growth tanks
that provide adequate physical means to
avoid the escape of the aquatic species,
its gametes, and introduced exogenous
genetic material. A mechanism shall be
provided to ensure that neither the
organisms nor their gametes can escape
into the supply or discharge system of
the rearing container (e.g., tank,
aquarium, etc.) Acceptable barriers
include appropriate filtration,
irradiation, heat treatment, chemical
treatment, etc. Moreover, the top of the
rearing container shall be covered to
avoid escape of the organism and its
gametes. In the event of tank rupture,
leakage, or overflow, the construction of
the room containing these tanks should
prevent the organisms and gametes from
entering the building’s drains before the
organism and its gametes have been
inactivated.
Other types of animals (e.g.,
nematodes, arthropods, and certain
forms of smaller animals) may be
accommodated by using the appropriate
BL1 through BL4 or BL1–P through
BL4–P containment practices and
procedures as specified in Appendices
G and L. Containment for arthropods is
described in the Arthropod
Containment Guidelines and
Addendum 1 Containment Practices for
Arthropods Modified with Engineered
Transgenes Capable of Gene Drive (see
Appendix G–III–B).
The term ‘‘helper virus’’ is used in
multiple sections of the NIH Guidelines
to refer to the missing functions
provided to a defective virus. However,
helper systems (e.g., transient
transfection systems, packaging cell
lines, replicon systems, etc.) are more
commonly used than a helper virus.
NIH OSP has interpreted the term
‘‘helper virus’’ to extend to the use of
helper systems because they are also
associated with the risk of generation of
replication competent virus. To clarify
the language in the NIH Guidelines, the
term ‘‘helper virus’’ will be replaced in
Sections III–D–3, and III–E–1 with the
term ‘‘helper systems’’.
The risk group classification in
Appendix B of two viruses, West Nile
virus and St. Louis encephalitis virus,
are proposed to be changed from RG3 to
RG2 to be consistent with the risk
assessment that is articulated in the
current edition of the BMBL.
Appendix B–III–D currently states in
part:
Appendix B–III–D. Risk Group 3
(RG3)—Viruses and Prions.
Alphaviruses (Togaviruses)—Group A
Arboviruses currently states in part:
—St. Louis encephalitis virus.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Flaviviruses—Group B Arboviruses
currently states in part:
—West Nile virus (WNV).
Appendix B–II–D is proposed to be
amended to state:
Appendix B–II–D. Risk Group 2
(RG2)—Viruses.
Alphaviruses (Togaviruses)—Group A
Arboviruses.
—St. Louis encephalitis virus.
Flaviviruses—Group B Arboviruses.
—West Nile virus (WNV).
Dated: August 3, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–17178 Filed 8–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Fogarty International
Center Advisory Board.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session can be accessed from the
Fogarty International Center website
(https://www.fic.nih.gov/About/
Advisory/Pages/default.aspx).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty
International Center Advisory Board.
Date: September 7–8, 2023.
Closed: September 7, 2023, 2:00 p.m.
to 4:00 p.m.
Agenda: To review and evaluate the
second level of grant applications.
Place: Fogarty International Center,
National Institutes of Health, Lawton
E:\FR\FM\10AUN1.SGM
10AUN1
Federal Register / Vol. 88, No. 153 / Thursday, August 10, 2023 / Notices
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892.
Open: September 8, 2023, 9:00 a.m. to
3:00 p.m.
Agenda: Update and discussion of
current and planned Fogarty
International Center activities.
Place: Fogarty International Center,
National Institutes of Health, Lawton
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892 (Virtual
Meeting).
Meeting Access: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty
International Center, 31 Center Drive,
Room B2C02, Bethesda, MD 20892,
301–495–1415, kristen.weymouth@
nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Persons listed on this notice.
The statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting
will be posted when available.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; High Impact,
Interdisciplinary Science in NIDDK Research
Areas.
Date: October 10, 2023.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michelle L. Barnard, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health
6707 Democracy Boulevard, Room 7353,
Bethesda, MD 20892–2542 (301) 594–8898
barnardm@extra.niddk.nih.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
(Catalogue of Federal Domestic
Assistance Program Nos. 93.106,
Minority International Research
Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special
International Postdoctoral Research
Program in Acquired Immunodeficiency
Syndrome; 93.168, International
Cooperative Biodiversity Groups
Program; 93.934, Fogarty International
Research Collaboration Award; 93.989,
Senior International Fellowship Awards
Program, National Institutes of Health,
HHS)
Dated: August 4, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–17141 Filed 8–9–23; 8:45 am]
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 4, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–17124 Filed 8–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Study
Section AA–1.
Date: October 17, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2120, MSC 6902, Bethesda, MD
20892, (301) 443–4032, anna.ghambaryan@
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Study Section.
Date: October 24, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, Office of Extramural
Activities, National Institute on Alcohol
Abuse and Alcoholism, 6700B Rockledge
Drive, Room 2120, MSC 6902, Bethesda, MD
20892, 301–443–4032, anna.ghambaryan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.273, Alcohol Research
Programs, National Institutes of Health, HHS)
Dated: August 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–17187 Filed 8–9–23; 8:45 am]
BILLING CODE 4140–01–P
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
17:28 Aug 09, 2023
Jkt 259001
PO 00000
Frm 00053
Fmt 4703
Sfmt 9990
54341
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 88, Number 153 (Thursday, August 10, 2023)]
[Notices]
[Pages 54340-54341]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17141]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Fogarty
International Center Advisory Board.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The open session can be accessed from the
Fogarty International Center website (https://www.fic.nih.gov/About/Advisory/Pages/default.aspx).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: September 7-8, 2023.
Closed: September 7, 2023, 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate the second level of grant
applications.
Place: Fogarty International Center, National Institutes of Health,
Lawton
[[Page 54341]]
Chiles International House (Stone House), 16 Center Drive, Conference
Room, Bethesda, MD 20892.
Open: September 8, 2023, 9:00 a.m. to 3:00 p.m.
Agenda: Update and discussion of current and planned Fogarty
International Center activities.
Place: Fogarty International Center, National Institutes of Health,
Lawton Chiles International House (Stone House), 16 Center Drive,
Conference Room, Bethesda, MD 20892 (Virtual Meeting).
Meeting Access: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx.
Contact Person: Kristen Weymouth, Executive Secretary, Fogarty
International Center, 31 Center Drive, Room B2C02, Bethesda, MD 20892,
301-495-1415, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Persons listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: https://www.fic.nih.gov/About/Advisory/Pages/default.aspx, where
an agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority
International Research Training Grant in the Biomedical and Behavioral
Sciences; 93.154, Special International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome; 93.168, International
Cooperative Biodiversity Groups Program; 93.934, Fogarty International
Research Collaboration Award; 93.989, Senior International Fellowship
Awards Program, National Institutes of Health, HHS)
Dated: August 4, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17141 Filed 8-9-23; 8:45 am]
BILLING CODE 4140-01-P
